Providence First Trust’s Eli Lilly LLY Stock Holding History

Providence First Trust’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.12M	Sell	1,222 -93	-7%	-$94.3K	0.4%	58
2025 Q4	$1.41M	Sell	1,315 -836	-39%	-$799K	0.49%	46
2025 Q3	$1.64M	Sell	2,151 -63	-3%	-$46.9K	0.57%	52
2025 Q2	$1.73M	Buy	2,214 +3	+0.1%	+$2.33K	0.61%	50
2025 Q1	$1.83M	Hold	2,211	–	–	0.74%	40
2024 Q4	$1.71M	Sell	2,211 -146	-6%	-$121K	0.64%	42
2024 Q3	$2.09M	Buy	2,357 +1,448	+159%	+$1.3M	0.89%	34
2024 Q2	$823K	Sell	909 -800	-47%	-$640K	0.37%	62
2024 Q1	$1.33M	Buy	1,709 +1,239	+264%	+$882K	0.58%	47
2023 Q4	$274K	Buy	+470	New	+$274K	0.13%	85

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Providence First Trust's LLY Position: Q1 2026 in Review

Providence First Trust reduced its Eli Lilly (LLY) stake by 7.1% in Q1 2026, selling an estimated $94.3K and leaving 1,222 shares worth $1.12M. The position accounts for 0.4% of the portfolio, ranked #58.

Providence First Trust first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.09M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Providence First Trust held 1,222 shares of Eli Lilly worth $1.12M as of Q1 2026.
Providence First Trust sold 93 Eli Lilly shares in Q1 2026, an estimated $94.3K.
Eli Lilly made up 0.4% of Providence First Trust's portfolio in Q1 2026, its #58 holding.
Providence First Trust first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
Providence First Trust's Eli Lilly position peaked at $2.09M in Q3 2024.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Providence First Trust's 13F filing for Q1 2026, filed 5 May 2026.